Abstract
The ingestion of psychostimulant drugs by humans imparts a profound sense of alertness and well-being. However, repeated use of these drugs in some individuals will induce a physiological state of dependence, characterized by compulsive behavior directed toward the acquisition and ingestion of the drug, at the expense of customary social obligations. Drugs of abuse and many other types of experiences share the ability to alter the morphology and density of neuronal dendrites and spines. Dopaminergic modulation of corticostriatal synaptic plasticity is necessary for these morphological changes. Changes in the density of dendritic spines on striatal neurons may underlie the development of this pathological pattern of drug-seeking behavior. Identifying proteins that regulate dopaminergic signaling are of value. A family of proteins, the regulators of G protein signaling (RGS) proteins, which regulate signaling from G protein-coupled receptors, such as dopamine and glutamate, may be important in this regard. By regulating corticostriatal synaptic plasticity, RGS proteins can influence presynaptic activity, neurotransmitter release, and postsynaptic depolarization and thereby play a key role in the development of this plasticity. Pharmacological agents that modify RGS activity in humans could be efficacious in ameliorating the dependence on psychostimulant drugs.
Similar content being viewed by others
References
Aizman O., Brismar H., Uhlen P., et al. (2000) Anatomical and physiological evidence for D1 and D2 dopamine receptor colocalization in neostriatal neurons. Nat. Neurosci. 3, 226–230.
Albin R. L., Young A. B., and Penney J. B. (1989). The functional anatomy of basal ganglia disorders. Trends Neurosci. 12, 366–375.
Anger T., Zhang W., and Mende U. (2004) Differential contribution of GTPase activation and effector antagonism to the inhibitory effect of RGS proteins on Gq-mediated signaling in vivo. J. Biol. Chem. 279, 3906–3915.
Aronin N., Chase K., Sagar S. M., Sharp F. R., and DiFiglia M. (1991) N-methyl-d-aspartate receptor activation in the neostriatum increases c-fos and fos-related antigens selectively in medium-sized neurons. Neuroscience 44, 409–420.
Bannon M. J., Pruetz B., Manning-Bog A. B., et al. (2002) Decreased expression of the transcription factor NURR1 in dopamine neurons of cocaine abusers. Proc. Natl. Acad. Sci. USA. 99, 6382–6385.
Barnett J. V. and Kuczenski R. (1986) Desensitization of rat striatal dopamine-stimulated adenylate cyclase after acute amphetamine administration. J. Pharmacol. Exp. Ther. 237, 820–825.
Berke J. D., Paletzki R. F., Aronson G. J., Hyman S. E., and Gerfen C. R. (1998) A complex program of striatal gene expression induced by dopaminergic stimulation. J. Neurosci. 18, 5301–5310.
Benzing T., Yaffe M. B., Arnould T., et al. (2000) 14-3-3 interacts with regulator of G protein signaling proteins and modulates their activity. J. Biol. Chem. 275, 28167–28172.
Benzing T., Kottgen M., Johnson M., et al. (2002) Interaction of 14-3-3 protein with regulator of G protein signaling 7 is dynamically regulated by TNFα. J. Biol. Chem. 277, 32954–32962.
Berman D. M., Kozasa T., and Gilman A. G. (1996) The GTPase-activating protein RGS4 stabilizes the transition state for nucleotide hydrolysis. J. Biol. Chem. 271, 27209–27212.
Bernstein L. S., Raminen S., Hague C., et al. (2004) RGS2 binds directly and selectively to the M1 muscarinic acetylcholine receptor third intracellular loop to modulate Gq/11α signaling. J. Biol. Chem. 279, 21248–21256.
Berretta S., Robertson H. A., and Graybiel A. M. (1992) Dopamine and glutamate agonists stimulate neuron-specific expression of Fos-like protein in the striatum. J. Neurophysiol. 68, 767–777.
Bhat R. V. and Baraban J. M. (1993) Activation of transcription factor genes in the striatum by cocaine: role of both serotonin and dopamine systems. J. Pharmacol. Exp. Ther. 267, 496–505.
Bishop G. B., Cullinan W. E., Curran E., and Gutstein H. B. (2002) Abused drugs modulate RGS4 mRNA levels in rat brain: comparison between acute drug treatment and a drug challenge after chronic treatment. Neurobiol. Dis. 10, 334–343.
Bouyer J. J., Park D. H., Joh T. H., and Pickel V. M. (1984) Chemical and structural analysis of the relation between cortical inputs and tyrosine hydroxylase-containing terminals in rat neostriatum. Brain Res. 302, 267–275.
Bowman E. P., Campbell J. J., Druey K. M., Scheschonka A., Kehrl J. H., and Butcher E. C. (1998) Regulation of chemotactic and proadhesive responses to chemoattractant receptors by RGS (regulator of G-protein signaling) family members. J. Biol Chem. 273, 28040–28048.
Burchett S. A., Volk M. L., Bannon M. J., and Granneman J. G. (1998) Regulators of G protein signaling: Rapid changes in mRNA abundance in response to amphetamine. J. Neurochem. 70, 2216–2219.
Burchett S. A. (1999a) Regulators of G protein signaling (RGS) in rat striatum: response to acute and repeated amphetamine administration. Ph.D. Thesis, Wayne State University School of Medicine, Detroit, MI.
Burchett S. A., Bannon M. J., and Granneman J. G. (1999b) RGS mRNA expression in the rat striatum: modulation by dopamine receptors and effects of repeated amphetamine administration. J. Neurochem. 72, 1529–1533.
Burchett S. A. (2000) The regulators of G protein signaling: a bestiary of protein-binding domains. J. Neurochem. 75, 1335–1351.
Burchett S. A., Flanary P., Aston C., et al. (2002) Regulation of stress response signaling by the N-terminal dishevelled/EGL-10/pleckstrin domain of Sst2, a regulator of G protein signaling in Saccharomyces cerevisiae. J. Biol. Chem. 277, 22156–22167.
Burchett S. A. (2003) In through the out door: nuclear localization of the regulators of G protein signaling. J. Neurochem. 87, 551–559.
Burgon P. G., Lee W. L., Nixon A. B., Peralta E. G., and Casey P. J. (2001) Phosphorylation and nuclear translocation of a regulator of G protein signaling (RGS10). J. Biol. Chem. 276, 32828–32834.
Bouhamden M., Michelhaugh S. K., Calin-Jageman I., Ahern-Djamali S., and Bannon M.J. (2004) Brain-specific RGS9-2 is localized to the nucleus via its unique proline-rich domain. Biochimica et Biophysica Acta 1691, 141–150.
Cabrera-Vera T. M., Hernandez S., Earls L. R., et al. (2004) RGS9-2 modulates D2 dopamine receptor-mediated Ca2+ channel inhibition in rat striatal cholinergic interneurons. Proc. Natl. Acad. Sci. USA. 101, 16,339–16,344.
Calabresi P., Maj R., Pisani A., Mercuri N. B., and Bernardi G. (1992) Long-term synaptic depression in the striatum: physiological and pharmacological characterization. J. Neurosci. 12, 4224–4233.
Calabresi P., Centonze D., Gubellini P., and Bernardi G. (1999a) Activation of M1-like muscarinic receptors is required for the induction of corticostriatal LTP. Neuropharmacology 38, 323–326.
Calabresi P., Centonze D., Gubellini P., Marfia G. A., and Bernardi G. (1999b) Glutamate-triggered events inducing corticostriatal long-term depression. J. Neurosci. 19, 6102–6110.
Calabresi P., Gubellini P., Centonze D., et al. (2000) Dopamine and cAMP-regulated phosphoprotein 32 kDa controls both striatal long-term depression and long-term potentiation, opposing forms of synaptic plasticity. J. Neurosci. 20, 8443–8451.
Cenci M. A., and Björklund A. (1993) Transection of corticostriatal afferents reduces amphetamine- and apomorphine-induced striatal Fos expression and turning behavior in unilaterally 6-hydroxy-dopamine-lesioned rats. Eur. J. Neurosci. 5, 1062–1070.
Centonze D., Grande C., Saulle E., et al. (2003a) Distinct roles of D1 and D5 dopamine receptors in motor activity and striatal synaptic plasticity. J. Neurosci. 23, 8506–8512.
Centonze D., Grande C., Usiello A., et al. (2003b) Receptor subtypes involved in the presynaptic and postsynaptic actions of dopamine on striatal interneurons. J. Neurosci. 23, 6245–6254.
Centonze D., Usiello A., Costa C., et al. (2004) Chronic haloperidol promotes corticostriatal long-term potentiation by targeting dopamine D2L receptors. J. Neurosci. 24, 8214–8222.
Cepeda C., Buchwald N. A., and Levine M. S. (1993) Neuromodulatory actions of dopamine in the neostriatum are dependent upon the excitatory amino acid receptor subtypes activated. Proc. Natl. Acad. Sci. USA. 90, 9576–9580.
Charpier S., Mahon S., and Deniau J. M. (1999) In vivo induction of striatal long-term potentiation by low-frequency stimulation of the cerebral cortex. Neuroscience 91, 1209–1222.
Chatterjee T. K. and Fisher R. A. (2000) Cytoplasmic, nuclear and Golgi localization of RGS proteins. J. Biol. Chem. 275, 24013–24021.
Chatterjee T. K., and Fisher R. A. (2002) RGS12TS-S localizes at nuclear matrix associated subnuclear structures and represses transcription: structural requirements for subnuclear targeting and transcriptional repression. Mol. Cell Biol. 22, 4334–4345.
Chatterjee T. K., Liu Z., and Fisher R. A. (2003) Human RGS6 Gene structure, complex alternative splicing and role of the N-terminus and G-protein G-subunit-like (GGL) domain in subcellular localization of RGS6 splice variants. J. Biol. Chem. 278, 30261–30271
Chatterjee T. K. and Fisher R. A. (2003) Mild heat-and proteotoxic stress promote unique subcellular trafficking and nucleolar accumulation of RGS6 and other RGS proteins the role of the RGS domain in stress-induced trafficking of RGS proteins. J. Biol. Chem. 278, 30272–30282.
Chen H., Clark M. A., and Lambert N. A. (2004) Endogenous RGS proteins regulate presynaptic and postsynaptic function: functional expression of RGS-insensitive Galpha subunits in central nervous system neurons, in Methods Enzymol., vol. 390, Siderovski D.P., ed., Elsevier, San Diego CA, pp. 190–204.
Chini B. and Parenti M. (2004) G protein coupled receptors in lipid rafts and caveolae: how, when and why do they go there? J. Mol. Endocrinol. 32, 325–338.
Cladman W. and Chidiac P. (2002) Characterization and comparison of RGS2 and RGS4 as GTPase-activating proteins for m2 muscarinic receptor-stimulated G (i). Mol. Pharmacol. 62, 654–659.
Choe E. S. and McGinty J. F. (2000) N-Methyl-d-aspartate receptors and p38 mitogen-activated protein kinase are required for cAMP-dependent cyclase response element binding protein and Elk-1 phosphorylation in the striatum. Neuroscience 101, 607–617.
Choe E. S. and McGinty J. F. (2001) Cyclic AMP and mitogen-activated protein kinases are required for glutamate-dependent cyclic AMP response element binding protein and Elk-1 phosphorylation in the dorsal striatum in vivo. J. Neurochem. 76, 401–412.
Choe E. S. and Wang J. Q. (2001) Group I metabotropic glutamate receptors control phosphorylation of CREB, Elk-1 and ERK via a CaMKII-dependent pathway in rat striatum. Neurosci. Lett. 313, 129–132.
Choe E. S. and Wang J. Q. (2002) CaMKII regulates amphetamine-induced ERK1/2 phosphorylation in striatal neurons. Neuroreport 13, 1013–1016.
Choe E. S., Chung K. T., Mao L., and Wang J. Q. (2002) Amphetamine increases phosphorylation of extracellular signal-regulated kinase and transcription factors in the rat striatum via group I metabotropic glutamate receptors. Neuropsy-chopharmacology 27, 565–575.
Cho H., Kozasa T., Takekoshi K., De Gunzburg J., and Kehrl J. H. (2000) RGS14, a GTPase-activating protein for Gialpha, attenuates Gialpha- and G13alpha-mediated signaling pathways. Mol. Pharmacol. 58, 569–576.
Cho H., Kim D. U., and Kehrl J. H. (2005) RGS14 is a centrosomal and nuclear-cytoplasmic shuttling protein that traffics to PML nuclear bodies following heat shock. J. Biol. Chem. 205, 805–814.
Cole A. J., Bhat R. V., Patt C., Worley P. F., and Baraban J. M. (1992) D1 dopamine receptor activation of multiple transcription factor genes in rat striatum. J. Neurochem. 58, 1420–1426.
Cunningham M. L., Waldo G. L., Hollinger S., Hepler J. R., and Harden T. K. (2001) Protein kinase C phosphorylates RGS2 and modulates its capacity for negative regulation of Galpha 11 signaling. J. Biol. Chem. 276, 5438–5444.
Das S., Grunert M., Williams L., and Vincent S. R. (1997) NMDA and D1 receptors regulate the phosphorylation of CREB and the induction of c-fos in striatal neurons in primary culture. Synapse 25, 227–233.
Davare M. A., Avdonin V., Hall D. D., et al. (2001) A beta2 adrenergic receptor signaling complex assembled with the Ca2+ channel Cav1.2. Science 293, 98–101.
Deisseroth K., Mermelstein P. G., Xia H., and Tsien R. W. (2003) Signaling from synapse to nucleus: the logic behind the mechanisms. Curr. Opin. Neurobiol. 13, 354–365.
Di Chiara G., Morelli M., and Consolo S. (1994) Modulatory functions of neurotransmitters in the striatum: ACh/dopamine/NMDA interactions. Trends Neurosci. 17, 228–233.
Doupnik C. A., Davidson N., Lester H. A., and Kofuji P. (1997) RGS proteins reconstitute the rapid gating kinetics of G-activated inwardly rectifying K+ channels. Proc. Natl. Acad. Sci. USA 94, 10461–10466.
Dowal L., Elliott J., Popov S., Wilkie T. M., and Scarlata S. (2001) Determination of the contact energies between a regulator of G protein signaling and G protein subunits and phospholipase C beta 1. Biochemistry 16, 414–421.
Druey K. M., Sullivan B. M., Brown D., et al. (1998) Expression of a GTPase-deficient Giα2 results in translocation of cytoplasmic RGS4 to the plasma membrane. J. Biol. Chem. 273, 18405–18410.
Drevets W. C., Gautier C., Price J. C., et al. (2001) Amphetamine-induced dopamine release in human ventral striatum correlates with euphoria. Biol. Psychiatry. 49, 81–96.
Dudman J. T., Eaton M. E., Rajadhyaksha A., et al. (2003) Dopamine D1 receptors mediate CREB phosphorylation via phosphorylation of the NMDA receptor at Ser897-NR1. J. Neurochem. 87, 922–934.
Dulin N. O., Sorokin A., Reed E., Elliot S., Kehrl J. H., and Dunn M. J. (1999) RGS3 inhibits G protein-mediated signaling via translocation to the membrane and binding to GαII. Mol. Cell Biol. 19, 714–723.
Everitt B. J. and Wolf M. E. (2002) Psychomotor stimulant addiction: a neural systems perspective. J. Neurosci. 22, 3312–3320.
Fiorentini C., Gardoni F., Spano P., Di Luca M., and Missale C. (2002) Regulation of dopamine D1 receptor trafficking and desensitization by oligomerization with glutamate N-methyl-d-aspartate receptors. J. Biol. Chem. 278, 20196–20202.
Fivaz M. and Meyer T. (2003) Specific localization and timing in neuronal signal transduction mediated by protein-lipid interactions. Neuron 40, 319–330.
Garzón J., Rodriguez-Muñoz M., López-Fando A., and Sánchez-Blázquez P. (2005) Activation of Mu-opioid receptors transfers control of G-subunits to the regulator of G-protein signaling RGS9-2. Role in receptor desensitization. J. Biol. Chem. 280, 8951–8960.
Gerdeman G. L., Partridge J. G., Lupica C. R., and Lovinger D. M. (2003) It could be habit forming: drugs of abuse and striatal synaptic plasticity. Trends Neurosci. 26, 184–192.
Gerfen C. R., Engber T. M., Mahan L. C., et al. (1990) D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science 250, 1429–1432.
Gerfen C. R., Keefe K. A., and Gauda E. B. (1995) D1 and D2 dopamine receptor function in the striatum: coactivation of D1- and D2-dopamine receptors on separate populations of neurons results in potentiated immediate early gene response in D1-containing neurons. J. Neurosci. 15, 8167–8176.
Geurts M., Hermans E., and Malateaux J.-M. (2002) Opposite modulation of regulators of G protein signaling-2 (RGS2) and RGS4 expression by dopamine receptors in the rat striatum. Neurosci. Lett. 333, 146–150.
Geurts M., Maloteaux J. M., and Hermans E. (2003) Altered expression of regulators of G-protein signaling (RGS) mRNAs in the striatum of rats undergoing dopamine depletion. Biochem. Pharmacol. 66, 1163–1170.
Gold S. J, Ni Y. G, Dohlman H. G., and Nestler E. J. (1997) Regulators of G-protein signaling (RGS) proteins: region-specific expression of nine subtypes in rat brain. J. Neurosci. 17, 8024–8037.
Gonzalez-Nicolini V. and McGinty J. F. (2002) Gene expression profile from the striatum of amphetamine-treated rats: a cDNA array and in situ hybridization and histochemical study. Gene Expression Patterns 1, 193–198.
Granneman J. G., Zhai Y., Zhengxian Z., et al. (1998) Molecular characterization of human and rat RGS 9L, a novel splice variant enriched in dopamine target regions, and chromosomal localization of the RGS 9 gene. Mol. Pharmacol. 54, 687–694.
Graybiel A. M., Moratalla R., and Robertson H. A. (1990) Amphetamine and cocaine induce drug-specific activation of the c-fos gene in striosome-matrix and limbic subdivisions of the striatum. Proc. Natl. Acad. Sci. USA 87, 6912–6916.
Graybiel A. M. (1995) Building action repertoires: memory and learning functions of the basal ganglia. Curr. Opin. Neurobiol. 5, 733–741.
Greengard P. (2001) The neurobiology of slow synaptic transmission. Science 294, 1024–1030.
Grewal S. S., Fass D. M., Yao H., Ellig C. L., Goodman R. H., and Stork P. J. (2000) Calcium and cAMP signals differentially regulate cAMP-responsive element-binding protein function via a Rap1-extracellular signal-regulated kinase pathway. J. Biol. Chem. 275, 34433–34441.
Gubellini P., Saulle E., Centonze D., et al. (2003) Corticostriatal LTP requires combined mGluR1 and mGluR5 activation. Neuropharmacology 44, 8–16.
Hardingham G. E., Arnold F. J., and Bading H. (2001) A calcium microdomain near NMDA receptors: on switch for ERK-dependent synapse-to-nucleus communication. Nat. Neurosci. 4, 565–566.
Harkins A. B., Cahill A. L., Powers J. F., Tischler A. S., and Fox A. P. (2004) Deletion of the synaptic protein interaction site of the N-type (CaV2.2) calcium channel inhibits secretion in mouse pheochromocytoma cells. Proc. Natl. Acad. Sci. USA 101, 15219–15224.
Harris D. and Batki S. L. (2000) Stimulant psychosis: symptom profile and acute clinical course. Am. J. Addict. 9, 28–37.
Hernández-López S., Bargas J., Surmeier D. J., Reyes A., and Galarraga E. (1997) D1 receptor activation enhances evoked discharge in neostriatal medium spiny neurons by modulating an L-type Ca2+ conductance. J. Neurosci. 17, 3334–3342.
Hernández-López S., Tkatch T., Perez-Garci E., et al. (2000) D2 dopamine receptors in striatal medium spiny neurons reduce L-type Ca2+ currents and excitability via a novel PLC [β] 1-IP3-calcineurin-signaling cascade. J. Neurosci. 20, 8987–8995.
Heximer S. P., Watson N., Linder M. E., Blumer K. J., and Hepler J. R. (1997) RGS2/GOS8 is a selective inhibitor of Gαq function. Proc. Natl. Acad. Sci. USA 94, 14389–14393.
Heximer S. P., Srinivasa S. P., Bernstein L. S., et al. (1999) G protein selectivity is a determinant of RGS2 function. J. Biol. Chem. 274, 34253–34259.
Heximer S. P., Lim H., Bernard J. L., and Blumer K. J. (2001) Mechanisms governing subcellular localization and function of human RGS2. J. Biol. Chem. 276, 14195–14203.
Hollinger S., Taylor J. B., Goldman E. H., and Hepler J. R. (2001) RGS14 is a bifunctional regulator of Galphai/o activity that exists in multiple populations in brain. J. Neurochem. 79, 941–949.
Hooks S. B., Waldo G. L., Corbitt J., Bodor E. T., Krumins A. M., and Harden T. K. (2003) RGS6, RGS7, RGS9, and RGS11 stimulate GTPase activity of Gi family G-proteins with differential selectivity and maximal activity. J. Biol. Chem. 278, 10087–10093.
Hu G. and Wensel T. G. (2002) R9AP, a membrane anchor for the photoreceptor GTPase accelerating protein, RGS9-1. Proc. Natl. Acad. Sci. USA 99, 9755–9760.
Huang C.-L., Slesiger P. A., Casey P. J., Jan Y. N., and Jan L. Y. (1995) Evidence that direct binding of G beta gamma is important for channel activation. Neuron 15, 1133–1143.
Hunt R. A., Edris W., Chanda P. K., Nieuwenhuijsen B., and Young K. H. (2003) Snapin interacts with the N-terminus of regulator of G protein signaling 7. Biochem. Biophys. Res. Commun. 303, 594–599.
Hunt T. W., Fields T. A., Casey P. J., and Peralta E. G. (1996) RGS10 is a selective activator of G alpha i GTPase activity. Nature 12, 175–177.
Iadarola M. J., Chuang E. J., Yeung C-L., et al. (1993) Induction and suppression of proto-oncogenes in rat striatum after single or multiple treatments with cocaine or GBR-12909, in NIDA Research Monographs Series, vol. 125, Grzanna, R., and Brown, R.M., eds., U. S. Government Printing Office, Washington, D.C., pp. 181–211.
Ingi T., Krumins A. M., Chidiac P., et al. (1998) Dynamic regulation of RGS2 suggests a novel mechanism in G protein signaling and neuronal plasticity. J. Neurosci. 18, 7178–7188.
Inoue A. and Okabe S. (2003) The dynamic organization of postsynaptic proteins: translocating molecules regulate synaptic function. Curr. Opin. Neurobiol. 13, 332–340.
Ishii M., Fujita S., Yamada M., Hosaka Y., and Kurachi Y. (2005) PtdIns (3, 4, 5) P3 and Ca2+/calmodulin competitively bind to the RGS domain of RGS4 and reciprocally regulate its action. Biochem. J. 385, 65–73.
Ito R., Dalley J. W., Robbins T. W., and Everitt B. J. (2002) Dopamine release in the dorsal striatum during cocaine-seeking behavior under the control of a drug-associated cue. J. Neurosci. 22, 6247–6253.
Jiang M., Spicher K., Boulay G., Wang Y., and Birnbaumer L. (2001) Most central nervous system D2 dopamine receptors are coupled to their effectors by Go. Proc. Natl. Acad. Sci. USA 98, 3577–3582.
Kammermeier P. J. and Ikeda S. R. (1999) Expression of RGS2 alters the coupling of metabotropic glutamate receptor 1a to M-type K+ and N-type Ca2+ channels. Neuron 22, 819–829.
Kebabian J. W. and Calne D. B. (1979) Multiple receptors for dopamine. Nature 277, 93–96.
Kehrl J. H., Srikumar D., Harrison K., Wilson G. L., and Shi C. S. (2002) Additional 5′ exons in the RGS3 locus generate multiple mRNA transcripts, one of which accounts for the origin of human PDZ-RGS3. Genomics 79, 860–868.
Koob G. F. (1992) Neural mechanisms of drug reinforcement. Ann. NY Acad. Sci. 654, 171–191.
Koob G. F. and Le Moal M. (2001) Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology 24, 97–129.
Konradi C., Leveque J. C., and Hyman S. E. (1996) Amphetamine and dopamine-induced immediate early gene expression in striatal neurons depends on post-synaptic NMDA receptors and calcium. J. Neurosci. 16, 4231–4239.
Krumins A. M., Barker S. A., Huang C., et al. (2004) Differentially regulated expression of endogenous RGS4 and RGS7. J. Biol. Chem. 279, 2593–2599.
Kutateladze T. G., Capelluto D. G., Ferguson C. G., et al. (2004) Multivalent mechanism of membrane insertion by the FYVE domain. J. Biol. Chem. 279, 3050–3057.
Lavine N., Ethier N., Oak J. N., et al. (2002) G protein-coupled receptors form stable complexes with in wardly rectifying potassium channels and adenylyl cyclase. J. Biol. Chem. 277, 46010–4619.
Lee K.-W., Hong J.-H., Choi I. Y., et al. (2002) Impaired D2 dopamine receptor function in mice lacking type 5 adenylyl cyclase. J. Neurosci. 22, 7931–7940.
Li Y., Kolb B. and Robinson T. E. (2003) The location of persistent amphetamine-induced changes in the density of dendritic spines on medium spiny neurons in the nucleus accumbens and caudate-putamen. Neuropsychopharmacology 28, 1082–1085.
Liu Z. and Fisher R. A. (2004) RGS6 interacts with DMAP1 and DNMT1 and inhibits DMAP1 transcriptional repressor activity. J. Biol. Chem. 279, 14120–14128.
Lodowski D. T., Pitcher J. A., Capel W. D., Lefkowitz R. J., and Tesmer J. J. (2003) Keeping G proteins at bay: a complex between G protein-coupled receptor kinase 2 and Gbetagamma. Science 300, 1256–1262.
Lu Q., Sun E. E., Klein R. S., and Flanagan J. G. (2001) Ephrin-B reverse signaling is mediated by a novel PDZ-RGS protein and selectively inhibits G protein-coupled chemoattraction. Cell 105, 69–79.
Luo X., Popov S., Bera A. K., Wilkie T. M., and Muallem S. (2001) RGS proteins provide biochemical control of agonist-evoked [Ca2+]i oscillations. Mol. Cell 7, 651–660.
Lüscher C., Nicoll R. A., Malenka R. C., and Muller D. (2000) Synaptic plasticity and dynamic modulation of the postsynaptic membrane. Nat. Neurosci. 3, 545–550.
Mao L. and Wang J. Q. (2002) Activation of metabotropic glutamate receptors mediates up-regulation of transcription factor mRNA expression in rat striatum induced by acute administration of amphetamine. Brain Res. 924, 167–175.
Martemyanov K. A. and Arshavsky V. Y. (2002) Non-catalytic domains of RGS9-1-Gβ5L play a decisive role in establishing its substrate specificity. J. Biol. Chem. 277, 32843–32848.
Martemyanov K. A., Hopp J. A., and Arshavsky V. Y. (2003a) Specificity of G protein-RGS protein recognition is regulated by affinity adapters. Neuron 38, 857–862.
Martemyanov K. A., Lishko P. V., Calero N., et al. (2003b) The DEP domain determines subcellular targeting of the GTPase activating protein RGS9 in vivo. J. Neurosci. 23, 10175–10181.
Martemyanov K. A., Yoo P. J., Skiba N. P., and Arshavsky V. Y. (2005) R7BP-A novel neuronal protein interacting with RGS proteins of the R7 family. J. Biol. Chem. 280, 5133–5136.
Masuho I., Itoh M., Itoh H., and Saitoh O. (2004) The mechanism of membrane translocation of regulator of G protein signaling (RGS) 8 induced by G-expression. J. Neurochem. 88, 161–168.
Mazzucchelli C., Vantaggiato C., Ciamei A., et al. (2002) Knockout of ERK1 MAP kinase enhances synaptic plasticity in the striatum and facilitates striatal-mediated learning and memory. Neuron 30, 807–820.
McLaughlin S., Wang J., Gambhir A., and Murray D. (2002) PIP2 and proteins: Interactions, oraganization and information flow. Annu. Rev. Biophys. Biomol. Struct. 31, 151–175.
Melliti K., Meza U., Fisher R., and Adams B. (1999) Regulators of G protein signaling attenuate the G protein-mediated inhibition of N-type Ca2+ channels. J. Gen. Physiol. 113, 97–109.
Melliti K., Meza U., and Adams B. A. (2001) RGS2 blocks slow muscarinic inhibition of N-type Ca2+ channels reconstituted in a human cell line. J. Physiol. 532.2, 337–347.
Miserendino M. J. and Nestler E. J. (1995) Behavioral sensitization to cocaine: modulation by the cyclic AMP system in the nucleus accumbens. Brain Res. 674, 299–306.
Mitchell J. and Vierkant A. D. (1991) Delusions and hallucinations of cocaine abusers and paranoid schizophrenics: a comparative study. J. Psychol. 125, 301–310.
Moratalla R., Robertson H. A., and Graybiel A. M. (1992) Dynamic regulation of NGFIA (zif268, egr1) gene expression in the striatum. J. Neurosci. 12, 2609–2622.
Moratalla R., Xu M., Tonegawa S., and Graybiel A. M. (1996) Cellular responses to psychomotor stimulant and neuroleptic drugs are abnormal in mice lacking the D1 dopamine receptor. Proc. Natl. Acad. Sci. USA 10, 14928–14933.
Murray D. and Honig B. (2002) Electrostatic control of the membrane targeting of C2 domains. Mol. Cell 9, 145–154.
Muslin A. J. and Xing H. (2000) 14-3-3 proteins: regulation of subcellular localization by molecular interference. Cell Signal. 12, 703–709.
Nair K. S., Balasubramanian N., and Slepak V. Z. (2002) Signal-dependent translocation of transducin, RGS9-1-Gbeta5L complex, and arrestin to detergent-resistant membrane rafts in photoreceptors. Curr. Biol. 12, 421–425.
Nishizuka M., Honda K., Tsuchiya T., Nishihara T., and Imagawa M. (2001) RGS2 promotes adipocyte differentiation in the presence of the peroxisome proliferators-activated receptor. J. Biol. Chem. 276, 29625–29627.
Niu J., Scheschonka A., Druey K. M., et al. (2002) RGS3 interacts with 14-3-3 via the N-terminal region distinct from the RGS domain. Biochem. J. 365, 6777–6784.
Packard M. G. and Knowlton B. J. (2002) Learning and memory functions of the basal ganglia. Annu. Rev. Neurosci. 25, 563–593.
Parent A. and Hazrati L.-N. (1995) Functional anatomy of the basal ganglia. I. The cortico-basal ganglia-thalamo-cortical loop. Brain Res. Rev. 20, 91–127.
Pawson T. and Scott J. D. (1997) Signaling through scaffold, anchoring, and adaptor proteins. Science 278, 2075–2080.
Pedram A., Razandi M., Kehrl J., and Levin E. R. (2000) Natriuretic peptides inhibit G protein activation. Mediation through cross-talk between cyclic GMP-dependent protein kinase and regulators of G protein-signaling proteins. J. Biol. Chem. 275, 7365–7372.
Pérez-Garci E., Bargas J., and Galarraga E. (2003) The role of Ca2+ channels in the repetitive firing of striatal projection neurons. Neuroreport 14, 1253–1256.
Ponting C. P. and Bork P. (1996) Pleckstrin’s repeat performance: a novel domain in G-protein signaling? Trends Biochem. Sci. 21, 245–246.
Popov S. G., Krishna U. M., Falck J. R., and Wilkie T. M. (2000) Ca2+/Calmodulin reverse phosphatidylinositol 3, 4, 5-triphosphate-dependent inhibition of regulators of G protein-signaling GTPase activating protein activity. J. Biol. Chem. 275, 18962–18968.
Rajadhyaksha A., Barczak A., Macias W., Leveque J. C., Lewis S. E., and Konradi C. (1999) L-Type Ca (2+) channels are essential for glutamate-mediated CREB phosphorylation and c-fos gene expression in striatal neurons. J. Neurosci. 19, 6348–6359.
Ravasz E., Somera A. L., Mongru D. A., Oltvai Z. N., and Barabasi A. L. (2002) Hierarchical organization of modularity in metabolic networks. Science 297, 1551–1555.
Reynolds J. N., Hyland B. I., and Wickens J. R. (2001) A cellular mechanism of reward-related learning. Nature 413, 67–70.
Roberts-Lewis J. M., Roseboom P. H., Iwaniec L. M., and Gnegy M. E. (1986) Differential down-regulation of D1-stimulated adenylate cyclase activity in rat forebrain after in vivo amphetamine treatments. J. Neurosci. 6, 2245–2251.
Robinson T. E. and Kolb B. (2004) Structural plasticity associated with exposure to drugs of abuse. Neuropharmacology 47, 33–46.
Rose J. J., Taylor J. B., Shi J., Cockett M. I., Jones P. G., and Hepler J. R. (2000) RGS7 is palmitoylated and exists as biochemically distinct forms. J. Neurochem. 75, 2103–2112.
Roseboom P. H. and Gnegy M. E. (1989) Acute in vivo amphetamine produces homologous desensitization of dopamine-stimulated adenylyl cyclase activities and decreases agonist binding to the D1 site. Mol. Pharamacol. 35, 139–147.
Roseboom P. H., Hewlett G. H., and Gnegy M. E. (1990) Repeated amphetamine administration alters the interaction between D1-stimulated adenylyl cyclase activity and calmodulin. J. Pharamacol. Exp. Ther. 255, 197–203.
Roy A. A., Lemberg K. E., and Chidiac P. (2003) Recruitment of RGS2 and RGS4 to the plasma membrane by G proteins and receptors reflect functional interactions. Mol. Pharmacol. 64, 587–593.
Saitoh O., Murata Y., Odagiri M., et al. (2002) Alternative splicing of RGS8 gene determines inhibitory function of receptor type-specific Gq signaling. Proc. Natl. Acad. Sci. USA 99, 10138–10143.
Salim S., Sinnarajah S., Kehrl J. H., and Dessauer C. W. (2003) Identification of RGS2 and type V adenylyl cyclase interaction sites. J. Biol. Chem. 278, 15842–15849.
Saugstad J. A., Marino M. J., Folk J. A., Hepler J. R., and Conn P. J. (1998) RGS4 inhibits signaling by group 1 metabotropic glutamate receptors. J. Neurosci. 18, 905–913.
Schiff M., Siderovski D. P., Jordan J. D., et al. (2000) Tyrosine-kinase dependent recruitment of RGS12 to the N-type calcium channel. Nature 408, 723–727.
Self D. W., Genova L. M., Hope BT., Barnhart W. J., Spencer J. J., and Nestler E. J. (1998) Involvement of cAMP-dependent protein kinase in the nucleus accumbens in cocaine self-administration and relapse of cocaine-seeking behavior. J. Neurosci. 18, 1848–1859.
Shen K., Teruel M. N., Connor J. H., Shenolikar S., and Meyer T. (2000) Molecular memory by reversible translocation of calcium/calmodulin-dependent protein kinase II. Nat. Neurosci. 3, 881–886.
Shi C. S., Lee S. B., Sinnarajah S., Dessauer C. W., Rhea S. G., and Kehrl J. H. (2001) Regulator of G-protein signaling 3 (RGS3) inhibits Gbeta 1 gamma 2-induced inositol phosphate production, mitogen-activated protein kinase activation, and Akt activation. J. Biol. Chem. 276, 24293–24300.
Sierra D. A., Popov S., and Wilkie T. M. (2000) Regulators of G-protein signaling in receptor complexes. Trends Cardiovasc. Med. 10, 263–268.
Sinnarajah S., Dessauer C. W., Srikumar D., et al. (2001) RGS2 regulates signal transduction in olfactory neurons by attenuating activation of adenylyl cyclase III. Nature 409, 1051–1055.
Song L., De Sarno P., and Jope R. S. (1999) Muscarinic receptor stimulation increases regulators of G protein signaling 2 mRNA levels through a protein kinase C mechanism. J. Biol. Chem. 274, 29689–29693.
Song L., Zmijewski J. W., and Jope R. S. (2001) RGS2: Regulation of expression and nuclear localization. Biochem. Biophys. Res. Comm. 283, 102–106.
Snow B. E., Hall R. A., Krumins A. M., et al. (1998) GTPase activating specificity of RGS12 and binding specificity of an alternatively spliced PDZ (PSD-95/Dlg/ZO-1) domain. J. Biol. Chem. 273, 17749–17755.
Snyder G. L., Fienberg A. A., Huganir R. L., and Greengard P. (1998) A dopamine/D1 receptor/ protein kinase A/dopamine- and cAMP-regulated phosphoprotein (Mr 32 kDa)/protein phosphatase-1 pathway regulate dephosphorylation of the NMDA receptor. J. Neurosci. 18, 10297–10303.
Stahelin R. V., Burian A., Bruzik K. S., Murray D., and Cho W. (2003) Membrane binding mechanisms of the PX domains of NADPH oxidase p40phox and p47phox. J. Biol. Chem. 278, 14469–14479.
Sung K. W., Choi S., and Lovinger D. M. (2001) Activation of group I mGluRs is necessary for induction of long-term depression at striatal synapses. J. Neurophysiol. 86, 2405–2412.
Surmeier D. J., Bargas J., Hemmings H. C., Jr., Nairn A. C., and Greengard P. (1995) Modulation of calcium currents by a D1 dopaminergic protein kinase/phosphatase cascade in rat neostriatal neurons. Neuron 14, 385–397.
Surmeier D. J., Song W. J., and Yan Z. (1996) Coordinated expression of dopamine receptors in neostriatal medium spiny neurons. J. Neurosci. 16, 6579–6591.
Tang W. X., Fasulo W. H., Mash D. C., and Hemby S. E. (2003) Molecular profiling of midbrain dopamine regions in cocaine overdose victims. J. Neurochem. 85, 911–924.
Taymans J. M., Wintmolders C., Te Riele P., Jurzak M., Groenewegen H. J., and Leysen J. E. (2002) Detailed localization of regulator of G protein signaling 2 messenger ribonucleic acid and protein in brain. Neuroscience 114, 39–53.
Taymans J.-M., Leysen J. E., and Xavier L. (2003) Striatal gene expression of RGS2 and RGS4 is specifically mediated by dopamine D1 and D2 receptors: clues for RGS2 and RGS2 and RGS4 functions. J. Neurochem. 84, 1118–1127.
Taymans J.-M., Kia H. K., Cruz C., Leysen J., and Langlois X. (2004) Dopamine receptor-mediated regulation of RGS2 and RGS4 mRNA differentially depends on ascending dopamine projections and time. European J. Pharmacol. 19, 2249–2260.
Taymans J.-M., Cruz C., Lesage A., Leysen J. E., and Langlois X. (2005) MK-801 alters RGS2 levels and adenylyl cyclase sensitivity in the rat striatum. Neuroreport 6, 159–162.
Teruel M. N. and Meyer T. (2000) Translocation and reversible localization of signaling proteins: a dynamic future for signal transduction. Cell 103, 181–184.
Terwilliger R. Z., Beitner-Johnson D., Sevarino K. A., Crain S. M., and Nestler E. J. (1991) A general role for adaptations in G-proteins and the cyclic AMP system in mediating the chronic actions of morphine and cocaine on neuronal function. Brain Res. 548, 100–110.
Tong J., Ross B. M., Schmunk G. A., et al. (2003) Decreased striatal dopamine D1 receptor-stimulated adenylyl cyclase activity in human methamphetamine users. Am. J. Psychiatry. 160, 896–903.
Tosetti P., Parente V., Taglietti V., Dunlap K., and Toselli M. (2003) Chick RGS2L demonstrates concentration-dependent selectivity for pertussis toxin-sensitive and-insensitive pathways that inhibit L-type Ca2+ channels. J. Physiol. 15, 157–169.
Ujike H. (2002) Stimulant-induced psychosis and schizophrenia: the role of sensitization. Curr. Psychiatry Rep. 4, 177–184.
Unterwald E. M., Fillmore J., and Kreek M. J. (1996) Chronic repeated cocaine administration increases dopamine D1 receptor-mediated signal transduction. Eur. J. Pharmacol. 318, 31–35.
Valjent E., Corvol J. C., Pages C., Bessen M. J., Maldonado R., and Caboche J. (2000) Involvement of the extracellular signal-related kinase cascade for cocaine-rewarding properties. J. Neurosci. 20, 8701–8709.
Vanderschuren L. J. and Everitt B. J. (2004) Drug seeking becomes compulsive after prolonged cocaine self-administration. Science 305, 1017–1019.
Volkow N. D., Wang G. J., Fowler J. S., et al. (1997) Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects. Nature 386, 830–833.
Wang X., Zeng W., Soyombo A. A., et al. (2005) Spinophilin regulates Ca2+ signalling by binding the N-terminal domain of RGS2 and the third intracellular loop of G protein-coupled receptors. Nat. Cell. Biol. 7, 405–411.
Wong H. C., Mao J., Nguyen J. T., et al. (2000) Structural basis of the recognition of the dishevelled DEP domain in the Wnt signaling pathway. Nat. Struct. Biol. 7, 1178–1184.
Worsley J. N., Moszczynska A., Falardeau P., et al. (2000) Dopamine D1 receptor protein is elevated in nucleus accumbens of human, chronic methamphetamine users. Mol. Psychiatry. 5, 664–672.
Xu X., Zeng W., Popov S., et al. (1999) RGS proteins determine signaling specificity of Gq-coupled receptors. J. Biol. Chem. 274, 3549–3556.
Yan Z., Song W. J., and Surmeier J. (1997) D2 dopamine receptors reduce N-type Ca2+ currents in rat neostriatal cholinergic interneurons through a membrane-delimited, protein-kinase-C-insensitive pathway. J. Neurophysiol. 77, 1003–10015.
Yan Z., Feng J., Fienberg A. A., and Greengard P. (1999) D(2) dopamine receptors induce mitogen-activated protein kinase and cAMP response element-binding protein phosphorylation in neurons. Proc. Natl. Acad. Sci. USA 96, 11607–11612.
Yuferov V., Kroslak T., Laforge K. S., Zhou Y., Ho A., and Kreek J. (2003) Differential gene expression in the rat caudate putamen after “binge” cocaine administration: advantage of triplicate microarray analysis. Synapse 48, 157–169.
Yui K., Goto K., Ikemoto S., et al. (1999) Neurobiological basis of relapse prediction in stimulant-induced psychosis and schizophrenia: the role of sensitization. Mol. Psychiatry 4, 512–523.
Zeng W., Xu X., Popov S., et al. (1998) The N-terminal domain of RGS4 confers receptor-selective inhibition of G protein signaling. J. Biol. Chem. 25, 34687–34690.
Zhang J. H., Barr V. A., Mo Y., Rojkova A. M., Liu S., and Simonds W. F. (2001) Nuclear localization of G protein beta 5 and regulator of G protein signaling 7 in neurons and brain. J. Biol. Chem. 276, 10284–10289.
Zhang L., Lou D., Jiao H., et al. (2004) Cocaine-induced intracellular signaling and gene expression are oppositely regulated by the dopamine D1 and D3 receptors. J. Neurosci. 24, 3344–3354.
Zhuang X., Belluscio L., and Hen R. (2000) Golfα mediates dopamine D1 receptor signaling. J. Neurosci. RC91, 1–5.
Zmijewski J. W., Song L., Harkins L., Cobbs C. S., and Jope R. S. (2001) Second messengers regulate RGS2 expression, which is targeted to the nucleus. Biochim. Biophys. Acta. 1541, 201–211.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Burchett, S.A. Psychostimulants, madness, memory ... and RGS proteins?. Neuromol Med 7, 101–127 (2005). https://doi.org/10.1385/NMM:7:1-2:101
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/NMM:7:1-2:101